Opportunity Information: Apply for RFA MH 21 241

Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required) (RFA-MH-21-241) is a National Institutes of Health (NIH) discretionary grant opportunity focused on preventing perinatal depression by closing key evidence gaps highlighted by the United States Preventive Services Task Force (USPSTF). It is described as a companion to RFA-MH-21-240 and supports clinical trial research under the R34 mechanism, which is typically used for early-stage or pilot clinical trial work aimed at developing, refining, or testing feasibility of interventions and the ways those interventions are delivered.

The central purpose of the FOA is to fund research that improves prevention efforts before or during the perinatal period by addressing two specific USPSTF-identified needs. First, it seeks better methods to identify which pregnant or postpartum individuals are at increased risk for developing perinatal depression and are most likely to benefit from preventive interventions. This can include work on risk stratification, screening approaches, predictive factors, or practical ways to identify higher-risk individuals in real-world settings. Second, it prioritizes research on how to improve the delivery of preventive interventions, meaning studies that test strategies to increase reach, uptake, engagement, completion, and overall effectiveness when interventions are implemented in routine care or community contexts. In other words, the emphasis is not only on whether prevention programs can work, but also on how to get them to the right people, at the right time, in ways that are accessible and sustainable.

A major theme running through the announcement is an explicit emphasis on underserved populations. Projects are expected to consider barriers that contribute to unequal access to prevention and care, such as limited availability of perinatal mental health services, transportation and childcare constraints, lack of culturally or linguistically appropriate services, stigma, insurance and cost issues, and structural inequities affecting maternal health outcomes. The FOA encourages applicants to design studies that meaningfully include underserved groups and that test delivery approaches that can realistically function in settings that serve them, including community-based and safety-net environments.

Eligibility is broad and includes many kinds of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations other than federally recognized tribal governments. Nonprofit organizations are eligible whether or not they hold 501(c)(3) status, as are for-profit organizations (other than small businesses) and small businesses. The FOA also highlights additional eligible applicant types that align with its underserved-population emphasis, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI). Faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions are also included as eligible applicants.

At the same time, there are clear limits related to foreign involvement. Non-domestic (non-U.S.) entities and non-domestic foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, meaning a U.S. applicant can include certain foreign elements or collaborations if they meet NIH policy requirements, even though the applicant organization itself must be domestic.

Administratively, this opportunity is run by NIH and falls under the health-related funding activity category, with CFDA numbers 93.242 and 93.313. The original closing date listed for the competition was November 9, 2021, and the FOA record notes a creation date of June 25, 2021. The listing does not provide an award ceiling or expected number of awards in the provided source fields, so applicants would normally need to consult the full FOA text for budget guidance, project period limits, and detailed review criteria. The key takeaway is that this is an NIH R34 clinical trial-required opportunity centered on improving identification of at-risk perinatal individuals and optimizing real-world delivery of preventive interventions, with a strong expectation that proposed work addresses access and equity for underserved populations.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.313.
  • This funding opportunity was created on 2021-06-25.
  • Applicants must submit their applications by 2021-11-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 21 241

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Systems Biology-Enabled Microbiome Research to Facilitate Predictions of Interactions and Behavior in the Environment

Previous opportunity: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 21 241

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 21 241) also looked into and applied for these:

Funding Opportunity
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) Apply for RFA DC 22 001

Funding Number: RFA DC 22 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) Apply for PAR 21 269

Funding Number: PAR 21 269
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required) Apply for RFA MH 21 240

Funding Number: RFA MH 21 240
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) Apply for PAR 21 204

Funding Number: PAR 21 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional) Apply for RFA HG 21 025

Funding Number: RFA HG 21 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 22 027

Funding Number: RFA AG 22 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 022

Funding Number: RFA AG 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 21 263

Funding Number: PAR 21 263
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 21 264

Funding Number: PAR 21 264
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Apply for RFA HG 21 001

Funding Number: RFA HG 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) Apply for RFA HG 21 002

Funding Number: RFA HG 21 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) Apply for PA 21 267

Funding Number: PA 21 267
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Apply for PA 22 047

Funding Number: PA 22 047
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 21 239

Funding Number: PAR 21 239
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) Apply for PA 22 048

Funding Number: PA 22 048
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) Apply for RFA AI 21 050

Funding Number: RFA AI 21 050
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) Apply for RFA RM 21 025

Funding Number: RFA RM 21 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 021

Funding Number: RFA AG 22 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 015

Funding Number: RFA AG 22 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) Apply for RFA AG 22 024

Funding Number: RFA AG 22 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 21 241", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: